Glasgow’s £40 million Health Innovation Hub (HIH) will only continue to flourish thanks to its world-leading capability in catalysing cutting-edge medical thinking and attracting fresh investment, believes one of the country’s leading healthcare innovation bodies

Last week, as the flagship Hub became home to a new clinical research centre offering heightened patient involvement in clinical trials and improved identification of new treatments, InnoScot Health called it “an exciting time for the city’s ambitions to shape the future of medicine amid a nine-figure opportunity”.

Head of Business Development at InnoScot Health, Frances Ramsay said: “According to Glasgow City Region, the local Health and Life Sciences sector now supports over 10,000 jobs and generates £325m annually. That equates to almost 60% of total turnover across the country—and HIH can help to lead the charge to further expansion, boosting that nine-figure growth.”

Former Health Minister and guest of honour Dr Zubir Ahmed MP stated that the new Panthera research centre would help to “ensure our city remains at the forefront of developing new treatments and improving healthcare” with the quality of HIH facilities playing an important role in its future success.

A recently published first annual report from the Glasgow Riverside Innovation District (GRID) described the opening of the 87,000 sq ft HIH earlier this year as a “major milestone for the city”—and InnoScot Health believes it will go from strength with further innovative organisations set to take up occupation, boosting Scotland’s life sciences capabilities as well as its economy.

Frances said: “With the new clinical research centre set to make a significant contribution to Glasgow’s growing life sciences sector, the HIH has taken on another fresh dimension which brings research participation closer to the public.

“Despite only opening its doors in March, the Hub is already a major focal point for precision medicine and digital health companies, providing access to world-leading academics, co-located industry partners, and close proximity to outstanding clinical infrastructure such as the adjacent Queen Elizabeth University Hospital (QEUH).

“With so many assets to its network, location, and interlocked partnerships, there is undoubtedly so much more to come from its ethos of connecting academic expertise, clinical capability, and commercial opportunity.

She added: “The HIH will only continue to flourish thanks to its world-leading capability in catalysing cutting-edge medical thinking and attracting fresh investment to the city, helping to make it an exciting time for Glasgow’s ambitions to shape the future of medicine”.

The GRID annual report noted that the facility—developed by Kadans Science Partner in collaboration with the University of Glasgow's Living Laboratory for Precision Medicine—has provided “a platform for translating research into solutions that can improve health outcomes and drive economic growth”.

It added: “Importantly, the Health Innovation Hub has been designed as more than a research facility.

“Through the University’s Living Lab, it is becoming a place where researchers, healthcare professionals, businesses, schools and local communities can engage with innovation.

“Public engagement, creative programmes and educational partnerships are making cutting-edge research more accessible, strengthening public trust and inspiring future talent.”

GRID is a collaboration between the University of Glasgow, Glasgow City Council, and Scottish Enterprise. It brings together academia, industry, the public sector and communities to promote inclusive, innovation-led economic growth.

Uzma Khan, vice-principal for economic development and innovation and chief operating officer at the University of Glasgow, said: “The success of GRID is underpinned by meaningful partnership and collaboration—bringing businesses, researchers, entrepreneurs, and partners together to deliver tangible success.

“Our Annual Report shows that this collaboration is delivering results. True partnership sits at the heart of our progress.”